Home
Conditions
BRCA2 Mutation

Clinical trial condition

BRCA2 Mutation

Explore clinical trials studying BRCA2 Mutation. Study availability and eligibility vary by location and protocol.

41 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

BRCA2 Mutation trial results

Recruiting

Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer

NCT06488378

Conditions: BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, +8 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

NCT05485766

Conditions: BRCA Mutation, BRCA-Associated Breast Carcinoma, BRCA1 Mutation, +11 more
Locations: Gifu University Hospital Gifu, Japan

Okayama University Hospital Okayama, Japan

St. Luke's International Hospital Tokyo, Japan

View Trial Details

Recruiting

Prostate Cancer Genetic Risk Evaluation and Screening Study

NCT05129605

Conditions: ATM Gene Mutation, BRCA1 Mutation, BRCA2 Mutation, +35 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2

NCT05898009

Conditions: BRCA2 Mutation, Breast Cancer, Breast Diseases, +8 more
Locations: Mireille IRABE Saint-Pierre, France

View Trial Details

Recruiting

Registry of Subjects at Risk of Pancreatic Cancer

NCT04095195

Conditions: BRCA1 Mutation, BRCA2 Mutation, Colonic Diseases, +34 more
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

Ospedale Pederzoli Peschiera del Garda, Verona, Italy

San Raffele Vita Salute University Hospital Milan, Italy

Chirurgia Generale e del Pancreas Verona, Italy

View Trial Details

Enrolling by Invitation

Genetic Education in BRCA Families

NCT03544983

Conditions: Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +23 more
Locations: Georgetown University Medical Center/Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

George Washington University Washington D.C., District of Columbia, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Geisinger Medical Center Danville, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

NCT07499999

Conditions: Adenocarcinoma, Ataxia Telangiectasia Mutated Gene Mutation, Atypical Lobular Hyperplasia, +16 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Evaluating Cascade Communication Methods

NCT04428736

Conditions: BRCA1 Mutation, BRCA2 Mutation
Locations: Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

NCT03685331

Conditions: Advanced Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, +8 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

The Genetic Education for Men Trial: Web-Based Education vs. Standard Care

NCT02957981

Conditions: BRCA1 Mutation, BRCA2 Mutation, Breast Diseases, +29 more
Locations: Georgetown University Medical Center/Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

View Trial Details

BRCA2 Mutation

BRCA2 Mutation trial results

Related conditions